Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple myeloma
Comorbidity C1332362|b-cell neoplasm
Sentences 1
PubMedID- 22404949 Although the clinical outcome of plasma cell myeloma when concomitant with other indolent b-cell neoplasms is unfavorable, our patient seemed to respond to high-dose bortezomib plus lenalidomide.

Page: 1